AMPH· Amphastar Pharmaceuticals In
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 4 quarters
AMPH Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$838M
Enterprise value$1.2B
EV / EBITDA (TTM)6.25
P/E ratio (TTM)11.45
Forward P/E5.64
P/S ratio1.16
P/B ratio1.10
PEG ratio—
Cash Flow
Operating cash flow (TTM)$169M
Free cash flow (TTM)$103M
Total cash$292M
Total debt$686M
Debt / equity88.75
Current ratio3.85
Income Statement
Total revenue (TTM)$721M
Revenue per share (TTM)15.61
Gross profit (TTM)$341M
EBITDA (TTM)$197M
Net income (TTM)$79M
EPS diluted (TTM)1.66
Shares outstanding44,092,919
Float shares32,950,197
Profitability
Gross margin47.34%
Operating margin7.96%
EBITDA margin27.38%
Net margin11.00%
Efficiency
Return on assets (TTM)5.34%
Return on equity (TTM)10.39%
Price History
Current price$19.00
52 Week high$31.26
52 Week low$17.03
50 day average$20.57
200 day average$25.11
Average volume (10 day)524,400
1-year beta0.97
1-year price target$26.43
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:35 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com